EMA proposes GMP update to EudraLex to address nitrosamine impurities
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesEuropeEuropean Medicines Agency (EMA)ManufacturingPharmaceuticalsQuality management system/QMSRegulatory Intelligence/Policy